Opinions of French patients with schizophrenia regarding injectable medication

Patient Preference and Adherence

Volumn 5, Issue , 2011, Pages 165-171

  Caroli, François ^a   Raymondet, Philippe ^b   Izard, Isabelle ^c   Plas, Joel ^d   Gall, Bérengère ^e   Delgado, Antonio ^f  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b CMP Chalucet   (France)

^c CMP Jean Wier   (France)

^d CH Jean Charcot   (France)

^e Opinion and Health Department   (France)

^f Neurosciences Department   (France)

Author keywords

Antipsychotic agents; Depot preparations; Dosage forms; Injections; Patient opinion; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; ETHNIC GROUP; FEMALE; FRENCH LANGUAGE; HEALTH SURVEY; HUMAN; JOB FINDING; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT PREFERENCE; QUESTIONNAIRE; SCHIZOPHRENIA; SELF REPORT; TABLET FORMULATION; TREATMENT OUTCOME;

EID: 84863222170     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S15337     Document Type: Article

References (28)

1. Altamura AC, Sassella F, Santini A, et al. Intramuscular preparations of antipsychotics: uses and relevance in clinical practice. Drugs. 2003; 63:493-512.
2. Barnes TR, McPhillips MA. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia. Int Clin Psychopharmacol. 1998;13 Suppl 3:S49-S57.
3. Lader M. Some adverse effects of antipsychotics: prevention and treatment. J Clin Psychiatry. 1999;60 Suppl 12:18-21.
4. Roberts LW, Geppert CM. Ethical use of long-acting medications in the treatment of severe and persistent mental illnesses. Compr Psychiatry. 2004;45:161-167.
5. Patel MX, de Zoysa N, Baker D, David AS. Antipsychotic depot medication and attitudes of community psychiatric nurses. J Psychiatr Ment Health Nurs. 2005;12:237-244.
6. Patel MX, Nikolaou V, David AS. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia. Psychol Med. 2003; 33:83-89.
7. Turner MS, Stewart DW. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. J Psychopharmacol. 2006; 20(Suppl 6):20-37.
8. McCabe R, Saidi M, Priebe S. Patient-reported outcomes in schizophrenia. Br J Psychiatry Suppl. 2007;50:S21-S28.
9. Phillips L, McCann E. The subjective experiences of people who regularly receive depot neuroleptic medication in the community. J Psychiatr Ment Health Nurs. 2007;14:578-586.
10. David AS, Adams C. Depot antipsychotic medication in the treatment of patients with schizophrenia: (1) meta-review; (2) patient and nurse attitudes. Health Technol Assess. 2001;5:1-61.
11. Walburn J, Gray R, Gournay K, Quraishi S, David AS. Systematic review of patient and nurse attitudes to depot antipsychotic medication. Br J Psychiatry. 2001;179:300-307.
12. Anderson D, Leadbetter A, Williams B. In defence of the depot clinic. The consumers' opinion. Psychiatr Bull. 1989;13:177-179.
13. Desai N. Switching from depot antipsychotics to risperidone: results of a study of chronic schizophrenia. Adv Ther. 1999;16:78-88.
14. Eastwood N, Pugh R. Long-term in depot clinics and patients' rights: an issue for assertive outreach. Psychiatr Bull. 1997;21:273-275.
15. Goldbeck R, Tomlinson S, Bouch J. Patients' knowledge and views of their depot neuroleptic medication. Psychiatr Bull. 1999;23:467-470.
16. Hoencamp E, Knegtering H, Kooy US, van Der Molen AEGM. Patient requests and attitude towards neuroleptics. Nord J Psychiatry. 1995; 49 Suppl 35:47-55.
17. Jacobsson L, Odling H. Psychological aspects of depot treatment of schizophrenic syndromes. Lakartidningen. 1980;77:3522-3526. Swedish.
18. Larsen EB, Gerlach J. Subjective experience of treatment, sideeffects, mental state and quality of life in chronic schizophrenic outpatients treated with depot neuroleptics. Acta Psychiatr Scand. 1996; 93:381-388.
19. Pan PC, Tantam D. Clinical characteristics, health beliefs and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic. Acta Psychiatr Scand. 1989;79: 564-570.
20. Pereira S, Pinto R. A survey of the attitudes of chronic psychiatric patients living in the community toward their medication. Acta Psychiatr Scand. 1997;95:464-468.
21. Singh V, Hughes G, Goh E. Depot clinic: consumers' viewpoint. Psychiatr Bull. 1995;19:728-730.
22. Warren B. Developing practice through clinical audit. Journal of Clinical Effectiveness. 1998;3:151-154.
23. Wistedt B. How does the psychiatric patient feel about depot treatment: compulsion or help? Nord J Psychiatry. 1995;49 Suppl 35:41-46.
24. Hovens JE, Roman B, van Dinther R. Patients with schizophrenia prefer long-acting injections. Schizophr Res. 2006;81 Suppl:S84.
25. Heres S, Schmitz FS, Leucht S, Pajonk FG. The attitude of patients towards antipsychotic depot treatment. Int Clin Psychopharmacol. 2007; 22:275-282.
26. Heres S, Hamann J, Kissling W, Leucht S. Attitudes of psychiatrists toward antipsychotic depot medication. J Clin Psychiatry. 2006;67: 1948-1953.
27. Lachaux B. Study of patients with schizophrenic pathologies. Journal de Psychiatrie. 2006;19:1-8. French.
28. Hamann J, Cohen R, Leucht S, Busch R, Kissling W. Do patients with schizophrenia wish to be involved in decisions about their medical treatment? Am J Psychiatry. 2005;162:2382-2384.